The virus spreads through intimate contact, not from monkeys
Em São Paulo, a morte de um jovem de 26 anos pela varíola dos macacos lembra que epidemias não escolhem apenas os vulneráveis pelo acaso — elas revelam as fragilidades que já existiam, silenciosas, antes da doença chegar. É o sexto óbito no Brasil, num momento em que a curva de novos casos começa a ceder e as primeiras vacinas finalmente tocam o solo brasileiro, ainda destinadas à ciência antes de chegarem às pessoas.
- Um homem de 26 anos morreu após mais de dois meses internado no Instituto Emílio Ribas, tornando-se a primeira vítima fatal da varíola dos macacos no estado de São Paulo.
- O padrão se repete nos seis óbitos registrados no Brasil: homens com comorbidades e sistemas imunológicos comprometidos, evidenciando que a doença golpeia com mais força quem já carrega outras batalhas.
- Apesar de São Paulo concentrar quase metade dos 8.340 casos confirmados no país, a transmissão mostra sinais de desaceleração — mas o vírus continua circulando pelo contato íntimo entre pessoas, não por macacos.
- As primeiras 9.800 doses de vacina chegaram ao Brasil em 4 de outubro, mas seguirão para estudos clínicos antes de qualquer campanha de vacinação em massa, deixando a população aguardando respostas que a ciência ainda está construindo.
A Secretaria de Saúde de São Paulo confirmou, na quarta-feira dia 12 de outubro, a primeira morte por varíola dos macacos no estado. O paciente tinha 26 anos, morava na capital e estava internado no Instituto de Infectologia Emílio Ribas há mais de dois meses. Ele apresentava múltiplas condições de saúde preexistentes e recebia tratamento antiviral de emergência. Com esse óbito, o Brasil chegou a seis mortes pela doença — as demais ocorreram no Rio de Janeiro e em Minas Gerais.
São Paulo acumulava 3.861 casos confirmados no momento do anúncio, mas a curva de novas infecções havia começado a desacelerar nas semanas anteriores. As autoridades aproveitaram para desfazer um equívoco que persiste no imaginário popular: o surto atual não tem relação com macacos. A transmissão ocorre pelo contato íntimo entre pessoas — abraços, beijos, relações sexuais, secreções respiratórias — e também pelo contato com objetos contaminados, como roupas, roupas de cama e toalhas.
No plano nacional, o Ministério da Saúde recebeu em 4 de outubro seu primeiro lote de vacinas: 9.800 doses desembarcadas no Aeroporto de Guarulhos. O país havia encomendado cerca de 50.000 doses ao fundo rotatório da Organização Pan-Americana da Saúde. Seguindo orientação da OMS, o Brasil destinará as doses iniciais a estudos clínicos para avaliar eficácia, resposta imunológica e segurança — só depois disso é que se decidirá como distribuir o restante do estoque.
O mapa do surto mostrava São Paulo como epicentro, com 3.843 casos, seguido pelo Rio de Janeiro com 1.120 e Minas Gerais com 514. As recomendações de prevenção permaneciam as mesmas: evitar contato íntimo com quem apresente lesões na pele, lavar as mãos com frequência, não compartilhar itens pessoais e usar máscara próximo a casos confirmados. O vírus avançava devagar, e os instrumentos para contê-lo começavam, finalmente, a chegar.
São Paulo's health department confirmed on Wednesday, October 12th, the state's first death from monkeypox. The patient was 26 years old and lived in the capital. He had been hospitalized at the Emílio Ribas Institute of Infectious Diseases for more than two months, and according to officials, he carried multiple underlying health conditions. His death marked the sixth fatality from the virus recorded across Brazil, with the others occurring in Rio de Janeiro and Minas Gerais.
At the time of the announcement, São Paulo had documented 3,861 confirmed cases of monkeypox. The trajectory of new infections had begun to slow in recent weeks, according to the state health secretariat. Officials took the opportunity to clarify a persistent misconception: the current outbreak has no connection to actual monkeys. The virus spreads through intimate and sexual contact between people—through embraces, kisses, massages, sexual relations, and respiratory secretions. It can also travel via contact with contaminated objects like clothing, bedding, towels, and surfaces that an infected person has touched.
The state did not disclose what specific health conditions the deceased patient had, only that he was receiving emergency antiviral treatment for severe cases. The pattern among the other five deaths in Brazil was consistent: the victims were men with existing health vulnerabilities and compromised immune systems. One death in Rio de Janeiro had not yet yielded detailed information.
Brazil's health ministry had just received its first shipment of monkeypox vaccines the week prior—9,800 doses that landed at Guarulhos International Airport on October 4th. The country had ordered approximately 50,000 doses total through the Pan-American Health Organization's rotating fund, with additional shipments expected by year's end. However, the initial vaccines would not go directly to the public. Following guidance from the World Health Organization, Brazil planned to use them first for clinical studies designed to gather evidence about the vaccine's effectiveness, immune response, and safety profile. Only after that data was collected would officials decide how to deploy the remaining doses.
The outbreak's geography was becoming clearer. As of October 7th, Brazil had 8,340 confirmed cases overall, with another 4,586 under investigation. São Paulo dominated the count with 3,843 cases, followed by Rio de Janeiro with 1,120 and Minas Gerais with 514. The state health secretariat emphasized several prevention measures: avoid intimate contact with anyone showing skin lesions; wash hands regularly with soap and water or alcohol-based sanitizer; do not share bedding, towels, utensils, cups, or personal items; and wear masks when around confirmed cases or their close contacts. The virus was spreading, but slowly, and the tools to understand and contain it were beginning to arrive.
Citas Notables
The patient had multiple underlying health conditions and was receiving emergency antiviral treatment for severe cases— São Paulo Health Secretariat
The current outbreak has no connection to actual monkeys; transmission is through intimate and sexual contact between people— São Paulo Health Secretariat
La Conversación del Hearth Otra perspectiva de la historia
Why did this particular patient die when so many others with monkeypox survive?
He had multiple underlying conditions that weakened his immune system. He was already vulnerable before the virus arrived. That's the pattern we're seeing—the virus itself isn't necessarily lethal, but it becomes lethal when it finds someone whose body can't fight back.
The health department didn't say what those conditions were. Why the silence?
They didn't release those details. Maybe privacy, maybe they're still investigating. But the pattern across all six deaths tells you something: this isn't a virus that kills healthy people. It's a virus that finds the cracks in people's health and exploits them.
So the vaccine arriving now—that's the turning point?
Not yet. They're not vaccinating people. They're studying the vaccine first. They want to know if it actually works before they use it. That's careful, but it also means the outbreak continues while they gather data.
Three thousand cases in São Paulo alone. That's a lot of people.
It is. But new cases are dropping. The virus spreads through intimate contact, and people are changing behavior—they're being careful. That's why the numbers are slowing down.
What happens if someone with a weak immune system gets infected right now, before the vaccine is available?
That's the risk. They have antivirals for severe cases, like the patient who died had. But antivirals aren't a cure. They're a tool. And not everyone survives even with the tool.